MADRID and CAMBRIDGE, Mass., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, Ticker: ORY), a clinical-stage biopharmaceutical company and a global leader in epigenetics, today announced that the European Medicines Agency (EMA) has authorized its Clinical Trial Application (CTA) to initiate a Phase II study of iadademstat, Oryzon’s potent and selective LSD1 inhibitor currently in clinical development in oncology and hematology, for the treatment of essential thrombocythemia ...

Core Viewpoint - VolitionRx Limited has received a notice of non-compliance from NYSE American regarding its continued listing standards due to insufficient stockholders' equity, requiring a plan to regain compliance by August 6, 2027 [1][2] Compliance Requirements - The company is not in compliance with Section 1003(a)(i), (ii), and (iii) of the NYSE American Company Guide, which mandates stockholders' equity of at least $2.0 million, $4.0 million, and $6.0 million respectively, based on reported losses over recent fiscal years [1] - Volition must submit a compliance plan by March 8, 2026, detailing actions to regain compliance [1] Delisting Proceedings - If the plan is not submitted or accepted, or if compliance is not achieved by the deadline, NYSE American will initiate delisting proceedings [1] - The common stock will continue to trade under the symbol "VNRX" with an added designation of ".BC" indicating "below compliance" status [1] Business Operations - The notice does not impact the ongoing business operations or reporting requirements of the company with the U.S. Securities and Exchange Commission [1] - Volition is committed to regaining compliance and plans to submit a detailed plan to the NYSE American [1]

智通财经记者从澳门科技大学官网获悉，朱健康已任澳门科技大学校长、副校监。 朱健康在致辞中说：澳门科技大学自2000年创校以来，在前四任校长和全体师生的共同努力下，已经成 长为澳门在校学生规模最大的综合性大学，在教学、科研和社会服务方面取得了令人瞩目的成就。大学 秉持"意诚格物"之校训，致力于培养爱国爱澳、具备国际视野与创新能力的高素质人才，为澳门"一国 两制"成功实践和国家发展作出了积极贡献。 稍早前，澳门科技大学官网在2025年12月19日发布消息，澳门科技大学任命朱健康为第五任校长，他将 于2026年1月履新。 朱健康主要从事新型CRISPR-Cas基因编辑技术的开发和应用（生物育种、分子检测和基因治疗）、表 观遗传学（DNA甲基化和去甲基化）、植物逆境生物学（植物对干旱、高盐、低温等非生物胁迫的应 答机理）和新型生物刺激剂开发等方面的研究。目前为止， 在Cell、Nature、Science、Nature Biotechnology 等主流学术期刊发表论文超过550篇，其中Cell、Nature、Science 论文18篇，总被引次数 15万余次；连续多年入选全球"高被引科学家"名单，是世界自然科学领域 ...

Core Insights - The conversation highlights the evolving understanding of biology, particularly the role of genes and DNA, challenging traditional views that consider them as the sole controllers of life [4][9][10] Group 1: Understanding of Genes and DNA - The author Philip Ball argues that genes and DNA should be viewed as "molecular resources" that cells utilize based on their environment rather than as strict instructions governing all biological processes [9][10] - The historical perspective of genes as a "code" directing all biological functions is deemed outdated, with a shift towards understanding the complex interactions within cells [8][9] - The concept of "selfish genes" is critiqued, suggesting that it oversimplifies the intricate regulatory mechanisms at play in biological systems [12][19] Group 2: Medical Implications - Ball emphasizes the need for a more holistic approach to medicine, moving beyond genetic-level interventions for diseases that may not primarily stem from genetic issues [10][11] - The discussion points out that many common diseases are influenced by higher-level biological processes rather than solely by genetic factors [10][11] - The author suggests that current medical practices often resemble trial-and-error methods rather than being based on a deep understanding of biological mechanisms [11][12] Group 3: Complexity of Biological Systems - The conversation addresses the complexity of cellular environments, likening them to crowded nightclubs rather than orderly factories, highlighting the chaotic interactions among molecules [27][29] - The role of biomolecular condensates in cellular processes is introduced, emphasizing the importance of understanding these structures for effective medical interventions [24][26] - The need for advanced imaging techniques, such as cryo-electron microscopy, is discussed as a means to better visualize and understand cellular dynamics [27][29] Group 4: Emergence and Agency in Biology - The concept of "agency" in biological systems is explored, suggesting that organisms, including cells, exhibit decision-making capabilities that go beyond mere genetic programming [30][32] - Ball argues that understanding the agency of living organisms is crucial for comprehending the essence of life, distinguishing it from non-living entities [32][34] - The discussion touches on the philosophical implications of human decision-making and its divergence from evolutionary imperatives, indicating a complex interplay between instinct and conscious choice [34][36] Group 5: Future Directions in Biological Research - The potential of AI in biological research is acknowledged, particularly in predicting gene regulation and understanding complex biological phenomena [21][23] - However, concerns are raised about the limitations of AI in providing mechanistic explanations for biological processes, emphasizing the need for a deeper understanding of underlying mechanisms [23][24] - The conversation concludes with a call for better narratives in biology that reflect its complexity and the agency of living systems, moving away from simplistic explanations [49][50]

Core Insights - The research led by Ni Xijun reconstructs the skull fossil of "Yunxian Man 2" and establishes a new evolutionary tree for the genus Homo, shedding light on the origins of the Dragon Man and Denisovans [1][8]. Group 1: Relationship with Modern Humans - The Yunxian Man is closely related to modern humans, sharing a common ancestor approximately 1 million years ago [2][3]. - The Dragon Man branch is more closely related to modern humans than the Neanderthal branch, which was previously thought to be a sister group to Homo sapiens [3][8]. Group 2: Classification of Denisovans - Denisovans are classified as part of the Dragon Man branch, although they are often considered an independent group due to limited fossil evidence [4][5]. - The classification of Denisovans remains debated, as they lack a formally recognized species name and are primarily identified through DNA fragments [4][5]. Group 3: Methodology and Technological Advances - The study introduces a novel approach to fossil reconstruction, focusing on assessing the potential inaccuracies in the reconstruction process rather than solely on precision [9][13]. - A statistical method was employed to analyze the stability of the evolutionary tree despite potential errors in the reconstruction, demonstrating a significant technical breakthrough [13][14]. Group 4: Fossil Significance - The age of the Yunxian Man fossil, estimated at 1 million years, is crucial for understanding the divergence of Homo sapiens from other branches [8][9]. - The research emphasizes the rarity of well-preserved fossils from this time period, making the Yunxian Man a unique specimen for evolutionary studies [8][9]. Group 5: Future Research Directions - The research team is open to further analysis and validation of their findings by other researchers using their publicly available database [32][34]. - There is potential for applying the new methodologies to other species, although challenges remain in reconstructing fossils that lack extensive data [30][31].

Summary of the Conference Call for 诺禾致源 (Nuohe Zhiyuan) Company Overview - **Company**: 诺禾致源 (Nuohe Zhiyuan) - **Period**: January to September 2025 Key Financial Metrics - **Total Revenue**: 15.81 billion CNY, up 4.05% year-on-year [2][3] - **Q3 Revenue**: 5.41 billion CNY, up 3.47% year-on-year [3] - **Overseas Revenue**: 7.92 billion CNY, up 4.1% year-on-year, accounting for 50.09% of total revenue [2][3] - **Q3 Overseas Revenue**: 2.58 billion CNY, down 0.48% year-on-year [3] - **Domestic Revenue**: 7.89 billion CNY, up 4% year-on-year [2] - **Q3 Domestic Revenue**: 2.82 billion CNY, up 7.37% year-on-year, and up 8.61% quarter-on-quarter [5] - **Gross Margin**: 41.9%, down 0.7 percentage points year-on-year [10] - **Net Profit**: 1.16 billion CNY, down 10.17% year-on-year, with a net profit margin of 7.31% [11] - **R&D Investment**: 56.1 million CNY in Q3, focusing on emerging fields [12] Revenue Breakdown by Market - **Americas**: Q3 revenue down 12% due to changes in research funding and policy impacts [4] - **EMEA**: Q3 revenue down 12%, affected by project completion and funding transitions [4] - **Europe**: Q3 revenue up 19%, indicating strong performance [4] - **Customer Segmentation**: 70% of revenue from universities and research institutions, 30% from hospitals and enterprises [6] Product and Service Performance - **Life Sciences Research Services**: Revenue of 5.52 billion CNY, up 6.21% year-on-year [7] - **Monitoring and Sequencing Platform Services**: Revenue of 7.7 billion CNY, up 3.23% year-on-year, but Q3 revenue down 3.42% [7] - **Emerging Business Contributions**: Approximately 32% of total revenue, up 4 percentage points year-on-year, with a growth of about 20% [8] R&D and Innovation - **R&D Focus Areas**: Single-cell genomics, spatial genomics, proteomics, metabolomics, epigenetics, and long-read sequencing [12][18] - **AI Integration**: Progress in AI applications, particularly in omics data analysis and virtual cell modeling [20][28] Market Challenges and Strategies - **Domestic Market Competition**: Increased competition leading to a 30% price drop; company aims to reduce competition through mergers and acquisitions [16][23] - **Geopolitical Impact**: U.S. market affected by geopolitical tensions, but the company maintains strong relationships in key regions [21] - **Cash Flow Management**: Operating cash flow was negative 87 million CNY for the first nine months, but turned positive in Q3 at 77 million CNY [14] Future Outlook - **Expansion Plans**: Continued investment in overseas markets, including new laboratories in Singapore and Europe [30] - **Focus on NGS and AI**: Anticipated growth in NGS applications and AI integration to enhance research capabilities [24][28] Additional Insights - **Customer Base Growth**: Stable customer structure with a slight increase in contributions from universities and research institutions [6] - **Cash Flow Volatility**: Short-term fluctuations in cash flow due to proactive risk management strategies [14] - **Regulatory Environment**: Ongoing adjustments to align with changing policies in the domestic and international markets [26][27]

Core Insights - The article discusses the emerging evidence that parental lifestyle, particularly exercise habits, can influence the health characteristics of their offspring in a non-DNA manner, suggesting that the benefits of exercise may be "written" into the life scripts of future generations [2][9]. Research Findings - A study published in Cell Metabolism reveals that sperm microRNAs can serve as carriers of epigenetic information, transmitting "exercise capacity and metabolic health" from exercising fathers to their offspring, providing direct molecular evidence for the hypothesis that "exercise can be inherited" [3][11]. - The research team established a long-term endurance exercise model in mice, showing that exercise significantly reshaped the expression profile of sperm microRNAs, with several related to mitochondrial metabolism, muscle development, and energy utilization being significantly upregulated [6][11]. - Offspring of exercising male mice exhibited enhanced endurance and metabolic health in adulthood, with increased skeletal muscle mitochondrial activity and a higher proportion of oxidative muscle fibers, indicating that paternal exercise initiates a "reprogramming" of gene expression networks in the offspring at fertilization [6][11]. Mechanistic Insights - To validate the causal role of this "RNA inheritance" mechanism, the research team injected sperm microRNAs from exercising and non-exercising male mice into normal fertilized eggs, demonstrating that only the offspring from the exercising group exhibited enhanced endurance and metabolic traits without altering DNA sequences [7][11]. - The study identifies that exercise training and overexpression of muscle PGC-1α reshape sperm microRNAs, which directly inhibit the function of the nuclear receptor co-repressor 1 (NCoR1) during early embryonic development, promoting mitochondrial biogenesis and oxidative metabolism [7][11]. Implications - The findings establish a causal relationship between paternal exercise, sperm microRNAs, and embryonic NCoR1 in the transgenerational transmission of exercise-induced phenotypes and metabolic adaptations, expanding the understanding of how lifestyle influences future generations [11][12]. - This research not only provides molecular evidence for how lifestyle can affect the next generation but also opens new avenues for developing intergenerational health promotion strategies based on exercise-induced epigenetic reprogramming [11][12].

Core Insights - The Chinese epigenetics industry has made significant progress in recent years, becoming a research hotspot in the life sciences field, with a market size projected to reach approximately 4.396 billion yuan in 2024, reflecting a year-on-year growth of 62.27% [1][8][10] - The growth is driven by advancements in technologies such as high-throughput sequencing and single-cell sequencing, leading to broader applications in disease diagnosis, treatment, basic research, and crop breeding [1][8][10] Industry Overview - Epigenetics studies heritable changes in gene expression that do not involve changes to the underlying DNA sequence, focusing on the regulation of genes at the transcriptional level [2][4] - Key epigenetic modifications include DNA methylation, histone modification, chromatin remodeling, and RNA modifications [2][4] Industry Development History - The exploration phase of epigenetics in China occurred from the 1940s to 1970s, with significant setbacks due to political influences [4][5] - The initial development phase from the 1980s to 1990s saw the introduction of international genetic theories and the beginning of research into DNA methylation and histone modifications [5][6] - From 2000 to 2010, rapid development occurred, with China participating in the Human Epigenome Project and launching significant research initiatives [6][8] - Since 2010, the industry has matured, with increased international collaboration and applications in disease mechanisms, agriculture, and environmental adaptation [6][8] Industry Value Chain - The upstream of the epigenetics industry includes raw materials such as biological reagents and nucleic acid extraction kits, as well as scientific equipment like high-throughput sequencers and bioinformatics software [7] - The midstream focuses on research and development, while the downstream applications span medical fields (e.g., cancer early screening and precision treatment) and agriculture [7] Market Size - The Chinese epigenetics market is expected to reach approximately 4.396 billion yuan in 2024, with a year-on-year growth of 62.27%, driven by technological advancements and increasing market demand [1][8][10] Industry Trends - Technological innovation and multi-omics integration are driving advancements in precision medicine, with AI and single-cell sequencing enhancing early cancer screening capabilities [12][13] - Applications of epigenetics are expanding into agriculture, environmental science, and health management, demonstrating versatility across various fields [13] - Policy support and market expansion are fostering a comprehensive innovation ecosystem, with increased gene testing coverage and collaboration in international research initiatives [14]

Core Viewpoint - The increase in autism diagnoses in the U.S. has raised public concern, but there is currently no conclusive scientific evidence linking the use of acetaminophen (Tylenol) during pregnancy to autism [1][2] Group 1: Autism Diagnosis and Prevalence - The U.S. government reported that in 2022, the diagnosis rate of autism among 8-year-old children reached a historic high, with 1 in 31 children diagnosed [1] - The global prevalence of autism among children is estimated at 1%, up from approximately 0.6% a decade ago [2] - The average age for autism diagnosis globally is 5 years, while in the U.S., it remains close to 4 years [3] Group 2: Causes and Risk Factors - The etiology of autism is not fully understood, but it is believed that neurodevelopmental characteristics may form during fetal brain development [3][4] - Genetic factors account for approximately 80% of the risk for autism, with increasing research focusing on the interaction between genetic and environmental factors [4] - Potential risk factors for autism include low birth weight, neonatal jaundice, complications during pregnancy or delivery, and parental health conditions such as obesity and diabetes [4] Group 3: Treatment and Research - Currently, there are no effective therapies to reverse autism, and treatment remains challenging [5][6] - The FDA recently approved a therapy involving calcium folinate (folic acid) for improving autism symptoms, but research on its efficacy is still in early stages [6] - Advances in understanding the neuroanatomy of autism are limited, making treatment development more difficult compared to other neurodevelopmental disorders like depression [7]

Core Concept - The article discusses the concept of the "triple helix" proposed by R.C. Lewontin, emphasizing the interaction and influence among genes, organisms, and the environment [1][8]. Group 1: Genetic Determinism Debate - Lewontin criticizes genetic determinism, arguing that the human genome differs by less than 0.1%, yet it is misused to explain social inequalities such as wealth, intelligence, and crime [5][6]. - He asserts that the environment is not merely a container but is actively shaped by organisms, which select and modify their surroundings [5][8]. - The completion of the Human Genome Project, according to Lewontin, will not achieve its intended purpose of identifying disease-causing genes through DNA comparison [5][6]. Group 2: Responses from Richard Dawkins - Richard Dawkins responds to Lewontin's critiques, clarifying that he never claimed genes determine everything, but rather that genetic differences can explain phenotypic variations [6]. - Dawkins emphasizes the directionality of evolution, countering Lewontin's and Gould's views on randomness in evolution by citing examples like the speed of cheetahs [6]. - He argues that moral responsibility should not be outsourced to science, maintaining a distinction between scientific conclusions and their political implications [6]. Group 3: Impact on Biological Sciences - The debate between Lewontin and Dawkins has had a lasting impact on the field of biology, with new perspectives emerging, such as those presented by behavior geneticist Kathryn Harden in her book "The Gene Lottery" [7]. - Harden attempts to find a middle ground, acknowledging the significant role of genes while also recognizing the influence of luck and the potential for social policies to mitigate genetic impacts [7]. - However, Lewontin remains critical of this middle ground, insisting that the interactions among genes, environment, and randomness are too complex to disentangle [7][8]. Group 4: Science as a Social Institution - Lewontin argues that science is not an isolated pursuit of truth but a social institution influenced by political and economic factors [10][11]. - The direction of scientific research is often driven by societal needs and interests, rather than purely by the quest for knowledge [10][12]. - Cultural and ideological contexts shape scientific inquiry, affecting research focus and methodologies across different societies [11][12]. Group 5: Historical Context and Future Implications - Historical examples illustrate the close relationship between biology and political ideologies, such as the use of Darwinian theory in imperialism and eugenics [12]. - The ongoing developments in biological sciences, particularly in the context of the COVID-19 pandemic, raise questions about the political implications of scientific advancements [12].